Merck Unites With Schering Plough But India Goes Slow On Integration; Operational Structure And Merger Issues Remain Foggy
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - It may have been a mega integration of operations of the two New Jersey-headquartered companies - Merck and Schering Plough - but it stays status quo in India and the affiliates of the two large companies will continue to operate independently till the final contours emerge "in the next few months.
You may also be interested in...
With More Vaccines For Low-Income Countries In Mind, Merck Signs JV With Wellcome Trust; India To Be Research And Manufacturing Hub
MUMBAI - New opportunities like preventive vaccines for developing countries are throwing up newer alliances between disparate stakeholders. In one such deal, New Jersey-headquartered Merck has formed a first-of-its-kind equal stake collaboration with Wellcome Trust of the United Kingdom to work on research and development of vaccines that can prevent diseases mainly in low-income countries
With Schering-Plough, Merck Will Have Better Reach And Larger Product Basket In India
MUMBAI - After a long spell of near-dormancy, in Dec. 2006, Schering-Plough's India unit roped in K.G. Ananthakrishnan from Pfizer India to head its fledgling arm with a mandate to revive the company
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).